Literature DB >> 24747750

Synthesis, characterization and anti-proliferative activity of heterocyclic hypervalent organoantimony compounds.

Yi Chen1, Kun Yu2, Nian-Yuan Tan2, Ren-Hua Qiu2, Wei Liu3, Ning-Lin Luo2, Le Tong4, Chak-Tong Au5, Zi-Qiang Luo6, Shuang-Feng Yin7.   

Abstract

Three heterocyclic hypervalent organoantimony chlorides RN(CH2C6H4)2SbCl (2a R = t-Bu, 2b R = Cy, 2c R = Ph) and their chalcogenide derivatives [RN(CH2C6H4)2Sb]2O (3a R = t-Bu, 3b R = Cy, 3c R = Ph) were synthesized and characterized by techniques such as (1)H NMR, (13)C NMR, X-ray diffraction, and elemental analysis. It is found that the anti-proliferative activity detected over these compounds can be attributed to the coordination bond between the antimony and nitrogen atoms of these compounds. Moreover, a preliminary study on mechanistic action suggests that the inhibition effect is ascribable to cell cycle arrest and cell apoptosis.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-proliferative activity; Apoptosis; Cell cycle arrest; Characterization; Hypervalent organoantimony; Synthesis

Mesh:

Substances:

Year:  2014        PMID: 24747750     DOI: 10.1016/j.ejmech.2014.04.026

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

Review 1.  Synthesis of sulfur-containing heterocycles via ring enlargement.

Authors:  Bakr F Abdel-Wahab; Saad Shaaban; Gamal A El-Hiti
Journal:  Mol Divers       Date:  2018-01-31       Impact factor: 2.943

2.  Synthesis of Some Novel Fused Pyrimido[4″,5″:5',6']-[1,2,4]triazino[3',4':3,4] [1,2,4]triazino[5,6-b]indoles with Expected Anticancer Activity.

Authors:  Rania S Ali; Hosam A Saad
Journal:  Molecules       Date:  2018-03-19       Impact factor: 4.411

3.  Synthesis, characterization and antibacterial activity of novel heterocycle, coumacine, and two of its derivatives.

Authors:  Yasser Fakri Mustafa
Journal:  Saudi Pharm J       Date:  2018-03-27       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.